The acid-sensing ion channel 1 (ASIC1) exists as two primary splice variants in mammals:
ASIC1a: Ubiquitously expressed in CNS neurons, mediates proton-gated cation currents, and contributes to acidosis-related pathologies
ASIC1b: Predominantly found in sensory neurons, with distinct pH sensitivity compared to ASIC1a
No peer-reviewed studies or commercial antibody products currently reference an "ASIC1c" isoform in humans or model organisms. This suggests either a nomenclature error (e.g., confusion with ASIC3/ACCN3) or reference to a hypothetical/obsolete classification.
The following table summarizes validated ASIC1-targeting antibodies with cross-reactivity data:
pH-Dependent Stability: ASC06-IgG1 retains structural integrity across pH 5.0–7.4, enabling therapeutic use in acidic microenvironments
Calcium Signaling Modulation: ASIC1 blockade reduces intracellular Ca²⁺ by 78% in 6H7 cells (p < 0.001 vs. controls)
Membrane Trafficking Inhibition: Anti-ASIC1 antibodies prevent acidosis-induced translocation from nucleus to membrane (82% reduction at 10 μg/mL)
Neuroprotection: 1 μM ASC06-IgG1 increases neuronal survival from 5% to 45% under pH 5.5 conditions
Atherosclerosis: ASIC1 inhibition restores ABCA1-mediated cholesterol efflux by 63% in acidotic macrophages (p < 0.01)
Cancer Biology: ASIC1 antibody pretreatment reduces acidosis-driven tumor invasiveness by 41% in triple-negative breast cancer models
No antibodies demonstrate exclusive specificity for purported "ASIC1c" isoforms
Commercial antibodies show variable performance:
No studies validate ASIC1 antibody efficacy in non-mammalian systems
KEGG: dre:407670
UniGene: Dr.120630
ASIC1c (acid-sensing ion channel 1C) is primarily recognized as a zebrafish-specific ASIC isoform (zASIC1.3), encoded by the accn2c gene. Unlike the well-characterized mammalian isoforms ASIC1a and ASIC1b, ASIC1c has been primarily documented in Danio rerio. The zebrafish ASIC1 family includes three distinct isoforms:
ASIC1a (zASIC1.2): Encoded by accn2b
ASIC1b (zASIC1.1): Encoded by accn2a
ASIC1c (zASIC1.3): Encoded by accn2c
It's important to note that while mammalian species primarily express ASIC1a and ASIC1b variants, no peer-reviewed studies currently reference an "ASIC1c" isoform in humans or other mammalian model organisms .
Commercial ASIC1c antibodies are primarily species-specific reagents targeting zebrafish proteins. In contrast, mammalian ASIC1 antibodies generally target ASIC1a or pan-ASIC1 epitopes and have been more extensively validated.
Key differences include:
Target specificity: ASIC1c antibodies target unique C-terminal epitopes specific to the zebrafish isoform
Cross-reactivity: Unlike many mammalian ASIC1 antibodies which often show cross-reactivity across species (human/mouse/rat), ASIC1c antibodies are typically zebrafish-specific
Applications: ASIC1c antibodies are primarily validated for ELISA and Western blot applications, while mammalian ASIC1 antibodies have broader application validation including IHC, ICC, IP, and functional studies
When selecting an ASIC1c antibody for zebrafish research, consider:
Epitope specificity: Verify the antibody targets unique regions of ASIC1c not shared with ASIC1a or ASIC1b
Validation data: Review Western blot data showing specific detection at the expected molecular weight (~60 kDa)
Production method: Antibodies raised against recombinant fragments generally show better specificity than those raised against synthetic peptides
Purification method: Antigen-affinity purified antibodies (as indicated for CSB-PA754595XA01DIL) provide superior specificity
Application compatibility: Ensure validation for your intended application (typically Western blot and ELISA for most commercial options)
Host species: Consider secondary antibody compatibility with your experimental design
Most commercial ASIC1c antibodies are rabbit polyclonal IgGs suitable for Western blot and ELISA applications .
Cross-reactivity is a significant concern when working with closely related ion channel family members. For zebrafish ASIC1c antibodies:
Sequence homology assessment: The three zebrafish ASIC1 isoforms (a, b, c) share significant homology, particularly in conserved domains
Validation requirements: Always validate antibody specificity using:
Knockdown/knockout controls
Overexpression systems
Competing peptide controls
Recommended controls: Include lysates from tissues known to preferentially express ASIC1c but not ASIC1a/b
To minimize cross-reactivity issues, some researchers employ epitope tagging strategies (HA, FLAG, etc.) rather than relying on isoform-specific antibodies, particularly for overexpression studies .
Based on available data for ASIC1c and related ASIC1 antibodies:
Sample preparation:
Use phosphate-buffered solution with protease inhibitors
For membrane proteins like ASIC1c, include mild detergents (0.05% DDM) in extraction buffers
Avoid freeze-thaw cycles of antibody solutions
Western blot protocol:
Primary antibody dilution: Typically 1:500-1:1000 for ASIC1 antibodies
Incubation: Overnight at 4°C provides optimal signal-to-noise ratio
Expected molecular weight: 60-70 kDa (unglycosylated), 80-90 kDa (glycosylated)
Recommended positive control: Zebrafish brain tissue lysate
Secondary antibody: Anti-rabbit IgG at 1:10,000-16,000 dilution
Optimization notes:
Blocking buffer: 5% non-fat milk in TBST typically provides lower background than BSA for ASIC antibodies
Signal detection: Infrared imaging systems offer superior quantification compared to chemiluminescence
Common issues with ASIC1c antibody specificity and their solutions:
Multiple bands on Western blot:
High background in immunostaining:
Cross-reactivity with other ASIC isoforms:
For subcellular localization studies of ASIC1c:
Immunofluorescence optimization:
Fixation: 4% paraformaldehyde for 15-20 minutes provides optimal epitope preservation
Permeabilization: 0.1% Triton X-100 for membrane proteins
Antibody dilution: Start with 1:100-1:200 for primary detection
Co-localization markers: Include membrane markers (Na⁺/K⁺-ATPase) and organelle markers
Trafficking studies approach:
Advanced imaging techniques:
Super-resolution microscopy for nano-scale localization
FRET-based approaches to study protein-protein interactions
Live-cell imaging with pH-sensitive probes to correlate localization with function
Based on studies of mammalian ASIC1a, pH changes can trigger significant translocation between subcellular compartments, with anti-ASIC1 antibodies showing the ability to prevent acidosis-induced translocation from nucleus to membrane (82% reduction at 10 μg/mL).
To investigate ASIC1c function in zebrafish neurons:
Functional blocking experiments:
Calcium signaling analysis:
Combine ASIC1c antibody applications with calcium imaging
Quantify changes in pH-dependent calcium influx
Compare responses to known ASIC channel blockers (amiloride, PcTx1)
Developmental neurobiology applications:
Use antibodies to track ASIC1c expression during zebrafish neural development
Correlate expression patterns with functional circuit formation
Implement morpholino knockdown paired with antibody detection
For experimental design, consider the approach used with mammalian ASIC1a where antibodies like ASC06-IgG1 demonstrated sustained (30 min) and dose-dependent inhibition of up to 80% of acid-induced currents with an IC₅₀ value of 85 ± 6 nM .
Given that ASIC channels are activated by acidic pH, experiments often require antibody stability under acidic conditions:
Antibody stability assessment:
Technical approach for acidosis studies:
Pre-test antibody binding under neutral conditions
Apply pH challenge separately from antibody incubation steps when possible
Include pH-stable controls in all experiments
Consider using F(ab) fragments for improved stability in some applications
Alternative strategies:
Use epitope-tagged constructs for overexpression studies
Consider nanobody-based approaches which may offer superior pH stability
Implement proximity labeling methods before pH challenge
Future research applications for ASIC1c antibodies include:
Comparative neurobiology:
Investigate evolutionary divergence between zebrafish ASIC1c and mammalian ASIC1 isoforms
Study functional conservation/divergence across vertebrate lineages
Map expression patterns in specialized neural circuits unique to zebrafish
Therapeutic development platforms:
Generate function-modulating antibodies similar to mammalian ASIC1a approaches
Screen for isoform-specific modulators using antibody competition assays
Develop zebrafish disease models for testing therapeutic antibodies
Advanced methodological approaches:
Single-molecule imaging combined with electrophysiology
In vivo imaging in transparent zebrafish larvae
Optogenetic approaches combined with antibody-based detection
Disease modeling applications:
| Application | Recommended Protocol | Validation Controls | Expected Results | Optimization Variables |
|---|---|---|---|---|
| Western Blot | 1:500-1:1000 dilution, overnight 4°C | Zebrafish brain lysate, Peptide competition | 60-70 kDa band (unglycosylated), 80-90 kDa (glycosylated) | Blocking buffer, Membrane isolation method |
| ELISA | 1:1000-1:5000 dilution | Recombinant protein standard curve | Linear detection range 0.1-10 ng/mL | Coating buffer pH, Blocking reagent |
| ICC/IF | 1:100-1:500 dilution | Expression system with/without target | Membrane localization | Fixation method, Permeabilization |
| Functional Studies | 0.1-1.0 μM IgG | Patch-clamp electrophysiology | Dose-dependent inhibition of acid-induced currents | Antibody format (IgG vs Fab) |